右额颞阵发性疼痛1月余,左侧肢体麻木10天……

2018-07-18 佚名 新乡医学影像

患者女,27岁 主诉:右额颞阵发性疼痛1月余,左侧肢体麻木10天。

病例简介

患者女,27岁 主诉:右额颞阵发性疼痛1月余,左侧肢体麻木10天。



■ 影像特点

右额顶部大脑凸面梭形均匀强化团块影,可见脑膜尾征,未见钙化,周边多发小血管流空影,临近颅骨内板不规则破坏,临近头皮脂肪层下可见新月形均匀强化影。

■ 病灶定位

病灶位于大脑凸面,宽基底,边界清晰,局部边缘可见脑脊液裂隙,临近皮质及脑表面血管明显受压移位,可见脑膜尾征,故病灶定位于脑外并向颅内侵犯。

诊断及鉴别诊断

1. 恶性脑膜瘤2血管外皮细胞瘤3转移瘤4淋巴瘤5浆细胞瘤。

脑膜瘤为最常见的脑外非胶质原发肿瘤,具有脑外肿瘤的征象。恶性脑膜瘤形态不规则,可见分叶,常有囊变、出血、坏死,信号不均。本例具有恶性特点,呈浅分叶,内未见血管影,骨质轻度破坏,与典型脑膜不符。另脑膜瘤成长缓慢,多见中年女性,本例较年轻且病史短,故应考虑其他肿瘤。

2. 血管外皮细胞瘤,原发少见,具有脑外肿瘤的特点,中年人多见,WHOⅡ级,相对恶性。呈不规则分叶状,囊变、坏死、出血多见,瘤旁水肿明显,骨板可见溶骨性骨质破坏。常累及大脑镰、小脑幕及硬膜窦,多窄基底相连。常呈不规则分叶状,多见于中年女性,与本例不符。

3. 脑膜转移瘤具有脑外肿瘤的征象,T1等/稍低信号,T2稍高信号,可出血、囊变、坏死。找到原发灶对此病诊断有帮助。本例MRI为均质等信号,其发生在青年,与转移瘤不符。

4. 硬脑膜型淋巴瘤是一种罕见的颅内原发性淋巴瘤的亚型,可发生于颅内的任何部位,大脑凸面常见。密度或信号多均匀,易发生临近骨质破坏,侵犯周边软组织。MRS特征性表现为明显的Lip峰,可帮助诊断。此外,淋巴瘤恶性高,进展快,病程短,符合本例表现。

5. 浆细胞瘤为常发生成人的浆细胞性恶性肿瘤,颅内分两型,颅骨浆细胞瘤和髓外浆细胞瘤。

髓外浆细胞瘤可发生于硬脑膜、脑组织等含网状细胞瘤的组织。硬脑膜型浆细胞瘤多呈实性,信号均匀,增强后均质强化,也可见脑膜尾征,但浆细胞瘤的临近骨质多呈溶骨性破坏。其他表现包括弥漫性的脑膜病变和少见的颅内血管源性水肿。

■ 术中所见

肿瘤位于额顶部、中央区、灰红色,实性,质韧,血管丰富,边界清,分离肿瘤和脑皮质界面,肿瘤侵蚀软脑膜,大部分界面粘连严重。

■ 病理结果

B细胞淋巴瘤。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=332630, encodeId=b3ce33263044, content=科学治疗该疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Jul 19 06:47:36 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332554, encodeId=2ef333255489, content=了解一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Jul 18 23:03:43 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332548, encodeId=a933332548b0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/14ea8297053212a2d130edfca5edcd84.jpg, createdBy=40692333906, createdName=122771c4m25暂无昵称, createdTime=Wed Jul 18 22:26:36 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332543, encodeId=375b332543af, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Jul 18 21:40:49 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332541, encodeId=019933254161, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Jul 18 21:29:16 CST 2018, time=2018-07-18, status=1, ipAttribution=)]
    2018-07-19 jyzxjiangqin

    科学治疗该疾病

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=332630, encodeId=b3ce33263044, content=科学治疗该疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Jul 19 06:47:36 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332554, encodeId=2ef333255489, content=了解一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Jul 18 23:03:43 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332548, encodeId=a933332548b0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/14ea8297053212a2d130edfca5edcd84.jpg, createdBy=40692333906, createdName=122771c4m25暂无昵称, createdTime=Wed Jul 18 22:26:36 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332543, encodeId=375b332543af, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Jul 18 21:40:49 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332541, encodeId=019933254161, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Jul 18 21:29:16 CST 2018, time=2018-07-18, status=1, ipAttribution=)]
    2018-07-18 天地飞扬

    了解一下谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=332630, encodeId=b3ce33263044, content=科学治疗该疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Jul 19 06:47:36 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332554, encodeId=2ef333255489, content=了解一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Jul 18 23:03:43 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332548, encodeId=a933332548b0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/14ea8297053212a2d130edfca5edcd84.jpg, createdBy=40692333906, createdName=122771c4m25暂无昵称, createdTime=Wed Jul 18 22:26:36 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332543, encodeId=375b332543af, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Jul 18 21:40:49 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332541, encodeId=019933254161, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Jul 18 21:29:16 CST 2018, time=2018-07-18, status=1, ipAttribution=)]
    2018-07-18 122771c4m25暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=332630, encodeId=b3ce33263044, content=科学治疗该疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Jul 19 06:47:36 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332554, encodeId=2ef333255489, content=了解一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Jul 18 23:03:43 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332548, encodeId=a933332548b0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/14ea8297053212a2d130edfca5edcd84.jpg, createdBy=40692333906, createdName=122771c4m25暂无昵称, createdTime=Wed Jul 18 22:26:36 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332543, encodeId=375b332543af, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Jul 18 21:40:49 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332541, encodeId=019933254161, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Jul 18 21:29:16 CST 2018, time=2018-07-18, status=1, ipAttribution=)]
    2018-07-18 liumin1987

    好学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=332630, encodeId=b3ce33263044, content=科学治疗该疾病, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Jul 19 06:47:36 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332554, encodeId=2ef333255489, content=了解一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Wed Jul 18 23:03:43 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332548, encodeId=a933332548b0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/20/14ea8297053212a2d130edfca5edcd84.jpg, createdBy=40692333906, createdName=122771c4m25暂无昵称, createdTime=Wed Jul 18 22:26:36 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332543, encodeId=375b332543af, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Jul 18 21:40:49 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332541, encodeId=019933254161, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Wed Jul 18 21:29:16 CST 2018, time=2018-07-18, status=1, ipAttribution=)]
    2018-07-18 wzb521zf

    一起学习学习

    0